Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

Molecular Oncology

Volumn 2, Issue 3, 2008, Pages 250-260

  Bayani, Jane ^a   Paliouras, Miltiadis ^b,c   Planque, Chris ^b,c   Shan, Shannon J C ^d   Graham, Cassandra ^a   Squire, Jeremy A ^e   Diamandis, Eleftherios P ^b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Chromosomal rearrangements; Human kallikreins; Ovarian cancer

Indexed keywords

TISSUE KALLIKREIN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CHROMOSOME 19Q; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; GENOMICS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHROMOSOME ABERRATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KALLIKREINS; OVARIAN NEOPLASMS; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 51249121119     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2008.07.001     Document Type: Article

References (46)

1. Adeyinka A., Kytola S., Mertens F., Pandis N., and Larsson C. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. Int. J. Mol. Med. 5 (2000) 235-240
2. Anisowicz A., Sotiropoulou G., Stenman G., Mok S.C., and Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. 2 (1996) 624-636
3. An International System for Human Cytogenetic Nomenclature. In: Shaffer L.G., and Tommerup N. (Eds). Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature (2005), S Karger AG, Basel
4. Baudis M. Progenetix cytogenetics online database. 2007.
5. Bayani J., and Squire J.A. Chapter 22: Cell biology of chromosomes and nuclei. In: Morgan K. (Ed). Current Protocols in Cell Biology (2000), John Wiley & Sons, Inc., Bethesda, MD
6. Bayani J., Brenton J.D., Macgregor P.F., et al. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res. 62 (2002) 3466-3476
7. Beheshti B., Karaskova J., Park P.C., Squire J.A., and Beatty B.G. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping. Mol. Diagn. 5 (2000) 23-32
8. Bickmore W.A., and Teague P. Influences of chromosome size, gene density and nuclear position on the frequency of constitutional translocations in the human population. Chromosome Res. 10 8 (2002) 707-715
9. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikrein in cancer. Nat. Rev. Cancer 4 (2004) 876-890
10. Borgono C.A., Michael I.P., and Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2 (2004) 257-280
11. Cremer T., Kreth G., Koester H., Dietzel S., and Fakan S. Chromosome territories, interchromatin domain compartment, and nuclear matrix: an integrated view of the functional nuclear architecture. Crit. Rev. Eukaryot. Gene. Expr. 10 (2000) 179-212
12. Cremer T., Kupper K., et al. Higher order chromatin architecture in the cell nucleus: on the way from structure to function. Biol. Cell 96 (2004) 555-567
13. Cohen P., Graves H.C., Peehl D.M., Kamarei M., Giudice L.C., and Rosenfeld R.G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75 (1992) 1046-1053
14. Craig J.M., and Bickmore W.A. The distribution of CpG islands in mammalian chromosomes. Nat. Genet. 7 (1994) 376-382
15. Diamandis E.P., and Yousef G.M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48 (2002) 1198-1205
16. Ghosh M.C., Grass L., Soosaipillai A., Sotiropoulou G., and Diamandis E.P. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 25 (2004) 193-199
17. Haese A., Graefen M., Becker C., et al. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. Prostate 54 (2003) 181-186
18. Kytölä S., Rummukainen J., Nordgren A., Karhu R., Farnebo F., Isola J., and Larsson C. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer 28 (2000) 308-317
19. Magklara A., Mellati A.A., Wasney G.A., et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 307 (2003) 948-955
20. Mitelman F, Johansson B, et al. Mitelman Database of Chromosome Aberrations in Cancer. 2006.
21. Mitelman F., Johansson B., and Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 7 (2007) 233-245
22. Neve R.M., Chin K., Fridlyand J., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515-527
23. Ni X., Zhang W., Huang K.C., Wang Y., Ng S.K., Mok S.C., Berkowitz R.S., and Ng S.W. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br. J. Cancer 91 (2004) 725-731
24. Paliouras M., and Diamandis E.P. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res. Treat. 102 (2007) 7-18
25. Paliouras M., Borgono C.A., and Diamandis E.P. Human tissue kallikreins: The cancer biomarker family. Cancer Lett. 249 (2007) 61-79
26. Pampalakis G., and Sotiropoulou G. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol. Chem. 387 (2006) 773-782
27. Pampalakis G., Diamandis E.P., and Sotiropoulou G. The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biol. Chem. 387 (2006) 795-799
28. Pandis N., Jin Y., Gorunova L., et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12 (1995) 173-185
29. Rao P.H., Harris C.P., Yan Lu X., et al. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer 33 (2002) 123-132
30. Rummukainen J., Kytola S., Karhu R., Farnebo F., Larsson C., and Isola J.J. Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping. Cancer Genet. Cytogenet 126 (2001) 1-7
31. Sadoni N., Langer S., Fauth C., et al. Nuclear organization of mammalian genomes. Polar chromosome territories build up functionally distinct higher order compartments. J. Cell Biol. 146 (1999) 1211-1226
32. Sasaki H., Kawano O., Endo K., et al. EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Oncol. Rep. 17 (2007) 319-323
33. Selvarajah S., Yoshimoto M., Park P.C., et al. The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma 115 (2006) 459-467
34. Shaw J.L.V., and Diamandis E.P. Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53 (2007) 423-432
35. Shinoda Y., Kozaki K.I., Imoto I., et al. Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci. 98 (2007) 1078-1086
36. Sidiropoulos M., Pampalakis G., Sotiropoulou G., et al. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumour Biol. 26 (2005) 324-336
37. Taetle R., Aickin M., Panda L., et al. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes Cancer 25 (1999) 46-52
38. Taetle R., Aickin M., Yang J.M., et al. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25 (1999) 290-300
39. Tomlins S.A., Rhodes D.R., Perner S., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
40. Tomlins S.A., Mehra R., Rhodes D.R., et al. TMPRSS2:ETVA4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 66 (2006) 3396-3400
41. van Bokhoven A., Caires A., Maria M.D., Schulte A.P., Lucia M.S., Nordeen S.K., Miller G.J., and Varella-Garcia M. Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines. Prostate 57 (2003) 226-244
42. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
43. Wang Y., Xue H., Cutz J.C., et al. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab. Invest. 85 (2005) 1392-1404
44. Yoshimoto M., Cutz J.C., Nuin P.A., et al. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet. Cytogenet. 169 (2006) 128-137
45. Yousef G.M., Chang A., Scorilas A., and Diamandis E.P. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276 (2000) 125-133
46. Yousef G.M., and Diamandis E.P. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr. Rev. 22 (2001) 184-204